Literature DB >> 18088511

Optimization and validation of a chromatographic method for the simultaneous quantification of six bioactive compounds in Rhizoma et Radix Polygoni Cuspidati.

Guangsheng Qian1, Sik-Yuen Leung, GuangHua Lu, Kelvin Sze-Yin Leung.   

Abstract

A reverse-phase HPLC method was developed for simultaneous quantification of six bioactive compounds in Rhizoma et Radix Polygoni Cuspidati. These compounds--polydatin (1), resveratrol (2), rhein (3), emodin (4), chrysophanol (5) and physcion (6)--were analysed from 24 authentic samples of the herb using UV HPLC. Based on the UV absorption characteristics of the six compounds, absorption wavelengths of 306 nm were chosen to quantify compounds 1 and 2, and 290 nm for compounds 3-6. A reliable and reproducible quantitative HPLC method for analysing authentic samples of Rhizoma et Radix Polygoni Cuspidati from different cultivation regions was developed. The results showed that the concentration of compound 1 in samples from Sichuan was almost 2 fold higher than that of samples acquired in Guangxi. Furthermore, compounds 3 and 5 were not found in all the samples tested. Thus, instead of using polydatin (1) and emodin (4) as markers for quality assessment, as in conventional practice, these findings show that compounds 2 and 6 are more suited to act as marker compounds for a more specific assessment of the quality of this herb.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18088511     DOI: 10.1211/jpp.60.1.0014

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  3 in total

1.  Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway.

Authors:  Ji Hye Kim; Byoungduck Park; Subash C Gupta; Ramaswamy Kannappan; Bokyung Sung; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

2.  Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.

Authors:  Yang Yang; Chuangang Li; Hong Li; Moli Wu; Changle Ren; Yuhong Zhen; Xiaochi Ma; Yunpeng Diao; Xiaodong Ma; Sa Deng; Jia Liu; Xiaohong Shu
Journal:  Oncotarget       Date:  2017-06-20

3.  Metabolic profile and structure-activity relationship of resveratrol and its analogs in human bladder cancer cells.

Authors:  Yang Yang; Guangyuan Zhang; Chuangang Li; Sihan Wang; Manning Zhu; Jinan Wang; Hangtian Yue; Xiaodong Ma; Yuhong Zhen; Xiaohong Shu
Journal:  Cancer Manag Res       Date:  2019-05-21       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.